Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Tech Coloproctol ; 23(8): 769-774, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31399891

ABSTRACT

BACKGROUND: Haemorrhoidal disease (HD) is a common colorectal condition that often requires surgical treatment. Less invasive procedures are usually more acceptable to patients. The aim of this study was to report the outcome of a novel and minimally invasive technique employing a radiofrequency ablation (RFA) energy (Rafaelo®) to treat HD. METHODS: A total number of 27 patients who had RFA for the treatment of HD were recruited to this study. The procedure was performed under deep sedation and local anaesthesia. Patients' demographics; haemorrhoid severity score (HSS); quality of life; pain and satisfaction scores; and recurrence rate were recorded. RESULTS: The mean age of the patients was 46 (SD 14) years, 18 (67%) males and 9 (33%) females. The mean body mass index was 25 (SD 4) kg/m2. The predominant symptom of all patients was per-rectal bleeding. HSS improved from 7.2 (SD 1.9) before the procedure to 1.6 (SD 1) after the procedure (p < 0.0001). Postoperative pain scores on a scale of 0-10 were 0, 2 (SD 2), 1 (SD 2), and 0 on immediate, day-1, day-3, and 2-month follow-up questionnaire. The mean satisfacion score was 9 (SD 1.5) out of 10 on 2-month follow-up. Mean time until patients returned to normal daily activity was 3 (SD 1) days following the procedure. Quality-of-life assessments including: visual analogue scale scores (before: mean 70, SD 23; after: mean 82, SD 16; p < 0.001) and EQ-5D-5L (before: mean 0.84, SD 0.15; after: mean 0.94, SD 0.13; p < 0.05) were significantly improved. The mean length of follow-up for recurrence of symptoms was 20 months (range 12-32 months). One patient (4%) reported the recurrence of rectal bleeding 12 months after the procedure. CONCLUSIONS: RFA for the treatment of HD is safe and effective in achieving symptomatic relief. It is associated with minimal postoperative pain and low incidence of recurrence.


Subject(s)
Catheter Ablation/methods , Hemorrhoids/surgery , Adult , Catheter Ablation/adverse effects , Female , Humans , Male , Middle Aged , Pain, Postoperative/epidemiology , Pain, Postoperative/etiology , Rectum/blood supply , Rectum/surgery , Recurrence , Treatment Outcome
3.
United European Gastroenterol J ; 7(2): 297-306, 2019 03.
Article in English | MEDLINE | ID: mdl-31080614

ABSTRACT

Background: Intrapapillary capillary loops (IPCLs) represent an endoscopically visible feature of early squamous cell neoplasia (ESCN) which correlate with invasion depth - an important factor in the success of curative endoscopic therapy. IPCLs visualised on magnification endoscopy with Narrow Band Imaging (ME-NBI) can be used to train convolutional neural networks (CNNs) to detect the presence and classify staging of ESCN lesions. Methods: A total of 7046 sequential high-definition ME-NBI images from 17 patients (10 ESCN, 7 normal) were used to train a CNN. IPCL patterns were classified by three expert endoscopists according to the Japanese Endoscopic Society classification. Normal IPCLs were defined as type A, abnormal as B1-3. Matched histology was obtained for all imaged areas. Results: This CNN differentiates abnormal from normal IPCL patterns with 93.7% accuracy (86.2% to 98.3%) and sensitivity and specificity for classifying abnormal IPCL patterns of 89.3% (78.1% to 100%) and 98% (92% to 99.7%), respectively. Our CNN operates in real time with diagnostic prediction times between 26.17 ms and 37.48 ms. Conclusion: Our novel and proof-of-concept application of computer-aided endoscopic diagnosis shows that a CNN can accurately classify IPCL patterns as normal or abnormal. This system could be used as an in vivo, real-time clinical decision support tool for endoscopists assessing and directing local therapy of ESCN.


Subject(s)
Artificial Intelligence , Esophageal Squamous Cell Carcinoma/diagnostic imaging , Esophageal Squamous Cell Carcinoma/pathology , Esophagoscopy , Neovascularization, Pathologic , Early Detection of Cancer , Esophagoscopy/methods , Female , Humans , Image Processing, Computer-Assisted , Male , Reproducibility of Results , Sensitivity and Specificity , Taiwan
4.
Dig Dis Sci ; 64(10): 2815-2822, 2019 10.
Article in English | MEDLINE | ID: mdl-30982210

ABSTRACT

BACKGROUND: The endoscopic detection of esophageal cancer is suboptimal in both patients referred with dyspeptic symptoms and those enrolled in Barrett's surveillance programs. MCM5 expression in cells collected from gastric fluid may be correlated with the presence of dysplasia or adenocarcinoma. Analysis of this biomarker may improve the detection of cancer. METHODS: Sixty-one patients were enrolled at a single UK referral center. From each patient, 5-10 ml of gastric fluid was aspirated endoscopically. Patients were categorized according to their histology, normal, non-dysplastic Barrett's (NDBE), high-grade dysplastic Barrett's (HGD), and esophageal adenocarcinoma (EAC). All histology was confirmed by Seattle protocol biopsies or endoscopic mucosal resection. Samples were centrifuged, and the cell pellet was lysed. MCM5 expression levels were quantified using a proprietary immunoassay. The mean MCM5 expression was compared between groups by Kruskal-Wallis test. ROC curves were also used to assess diagnostic utility. RESULTS: The mean expression of MCM5 increases as patients progress from a normal esophagus to NDBE, HGD, and EAC (14.4; 49.8; 112.3; and 154.1, respectively). There was a significant difference in the MCM5 expression of patients with a normal esophagus compared to those with EAC (p = 0.04). There was a trend toward higher MCM5 expression in patients with EAC compared to those with NDBE (p = 0.34). MCM5 expression was a fair discriminator (AUC 0.70 [95% CI 0.57-0.83]) between patients without neoplasia (normal and NDBE) and those with early neoplasia (HGD and EAC). CONCLUSION: MCM5 expression in gastric fluid samples can differentiate patients with a histologically normal esophagus compared to those with early adenocarcinoma. Larger, powered studies are needed to assess whether it can be used to differentiate those with HGD from NDBE.


Subject(s)
Adenocarcinoma , Barrett Esophagus , Cell Cycle Proteins/analysis , Esophageal Neoplasms , Gastric Juice/metabolism , Precancerous Conditions , Adenocarcinoma/diagnosis , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Barrett Esophagus/diagnosis , Barrett Esophagus/metabolism , Barrett Esophagus/pathology , Biomarkers/analysis , Biopsy/methods , DNA Replication , Disease Progression , Early Detection of Cancer/methods , Endoscopy, Digestive System/methods , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/pathology , Feasibility Studies , Female , Humans , Male , Middle Aged , Precancerous Conditions/diagnosis , Precancerous Conditions/metabolism , Precancerous Conditions/pathology
5.
Mar Drugs ; 12(12): 5864-80, 2014 Dec 04.
Article in English | MEDLINE | ID: mdl-25486111

ABSTRACT

Five new polyoxygenated marine steroids-punicinols A-E (1-5)-were isolated from the gorgonian Leptogorgia punicea and characterized by spectroscopic methods (IR, MS, 1H, 13C and 2-D NMR). The five compounds induced in vitro cytotoxic effects against lung cancer A549 cells, while punicinols A and B were the most active, with IC50 values of 9.7 µM and 9.6 µM, respectively. The synergistic effects of these compounds with paclitaxel, as well as their effects on cell cycle distribution and their performance in the clonogenic assay, were also evaluated. Both compounds demonstrated significant synergistic effects with paclitaxel.


Subject(s)
Anthozoa/chemistry , Steroids/chemistry , Steroids/pharmacology , Animals , Cell Cycle/drug effects , Cell Line, Tumor , Drug Synergism , Humans , Lung Neoplasms/drug therapy , Magnetic Resonance Spectroscopy/methods , Paclitaxel/pharmacology
6.
Pediatrics ; 107(4): 728-35, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11335751

ABSTRACT

OBJECTIVES: There is mounting concern about how mothers' own victimization experiences affect their children. This study examines the effects of mothers' victimization on their own mental health and parenting and on their children's behavior, development, and health. The effects of both timing and type of victimization are assessed. A related objective was to determine if there was a cumulative risk effect produced by victimization during both childhood and adulthood, or both physical and sexual. SETTING: Urban families in an eastern state and urban and rural families in a southern state. PARTICIPANTS: A total of 419 mothers and their children 6 to 7 years old were identified from 2 sites. The eastern sample was recruited in the first 2 years of life from 3 pediatric clinics: 1 for children at high risk for human immunodeficiency virus disease, 1 for children with failure to thrive, and a third providing pediatric primary care. The southern sample was derived from a cohort of children at risk for adverse health or developmental outcomes, plus a systematic sampling of controls, recruited from area hospitals. At age 4, a random sample of children from the original cohort who had been maltreated along with a matched comparison group of nonmaltreated children were selected. RESULTS: In general, mothers victimized during both childhood and adulthood had poorer outcomes than mothers victimized during either childhood/adolescence or adulthood who in turn had worse outcomes than mothers with no history of victimization. This manifested as more maternal depressive symptoms, harsher parenting, and more externalizing and internalizing behavior problems in their children. There were no significant differences in maternal functioning or child outcomes between those abused in childhood and those abused in adulthood. These findings were similar for type of victimization. Mothers' depression and harsh parenting were directly associated with their children's internalizing and externalizing behavior problems. CONCLUSIONS: Maternal victimization appears to be a highly prevalent problem in high-risk samples and is associated with harmful implications for mental health and parenting, as well as for the offspring. Pediatricians need to consider past and current victimization of mothers. Routine screening for these problems, followed by appropriate evaluation and intervention may reduce maternal depression, improve parenting, and reduce the incidence of behavior problems in children.


Subject(s)
Child Abuse/statistics & numerical data , Child Behavior Disorders/epidemiology , Child of Impaired Parents/statistics & numerical data , Depressive Disorder/epidemiology , Mothers/statistics & numerical data , Violence/statistics & numerical data , Adult , Age Factors , Child , Child Abuse/psychology , Child Abuse, Sexual/psychology , Child Abuse, Sexual/statistics & numerical data , Child Behavior Disorders/diagnosis , Child Behavior Disorders/etiology , Child of Impaired Parents/psychology , Child, Preschool , Depressive Disorder/diagnosis , Depressive Disorder/etiology , Domestic Violence/psychology , Domestic Violence/statistics & numerical data , Female , Humans , Male , Mothers/psychology , Parent-Child Relations , Parenting/psychology , Prevalence , Psychiatric Status Rating Scales , Risk Factors , Rural Population , United States/epidemiology , Urban Population , Violence/psychology
7.
Z Rheumatol ; 59 Suppl 2: II/124-6, 2000.
Article in English | MEDLINE | ID: mdl-11155793

ABSTRACT

Many Gulf War veterans complain of a variety of symptoms including skin rashes and joint pain which may have a common immunological basis. Other Gulf War veterans have post-traumatic stress disorder (PTSD), an anxiety disorder associated with chronic stress. Whether or not chronic stress may affect the capacity to resist disease has not been fully delineated, but recent work suggests that a dysregulated balance of cytokines produced by T helper cells of the immune system may play a role in stress-related illnesses. It is known that a balanced immune response (cell-mediated and humoral immunity) is an important defense mechanism. Although the mechanism(s) by which a change in immune system balance occurs is not clear, it may be secondary to stress-induced changes in hormones such as cortisol and catecholamines, both of which have been implicated in altering levels of cellular or humoral immunity. For these reasons, we are investigating the function of both the cellular and humoral arms of the immune system as well as the cytokine patterns associated with these different functions in symptomatic Gulf War veterans and control groups consisting of asymptomatic Gulf War veterans and symptomatic non-Gulf War veterans.


Subject(s)
Cytokines/blood , Persian Gulf Syndrome/immunology , Stress, Psychological/complications , T-Lymphocytes/immunology , Veterans , Adult , Antibody Formation/immunology , Female , Humans , Lymphocyte Activation/immunology , Male , Middle Aged , Reference Values
8.
Ann N Y Acad Sci ; 876: 413-8, 1999 Jun 22.
Article in English | MEDLINE | ID: mdl-10415636

ABSTRACT

The role of stress and immunological abnormalities, as well as the neuroendocrine regulation of these two variables, in illnesses in Gulf War veterans (GWVs) is unknown. Many GWV patients complain of skin and joint problems, that is, disorders that may have a common immunological basis. Post-traumatic stress disorder (PTSD), an anxiety disorder associated with chronic stress, is diagnosed in approximately 10% of the Alabama GWVs. Chronic stress can lead to a reduced capacity to resist disease. Recent work suggests that a dysregulated balance of cytokines produced by T helper cells of the immune system can play a significant role in stress-related illnesses. Indeed, a balanced immune response (cell-mediated and humoral immunity) is an important defense mechanism, and cytokines can regulate this balance. It is therefore plausible that stress-induced changes in hormones (such as cortisol and catecholamines) and cytokines, both of which have been implicated in altering levels of cellular or humoral immunity, may play a role in GWV illnesses.


Subject(s)
Immune System/physiopathology , Persian Gulf Syndrome/physiopathology , Stress, Physiological/physiopathology , Veterans , Humans
9.
J Clin Immunol ; 18(6): 430-9, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9857288

ABSTRACT

X-linked hyper-IgM syndrome (XHIM) is a severe congenital immunodeficiency caused by mutations in CD154 (CD40 ligand, gp39), the T cell ligand for CD40 on B cells. Chronic or cyclic neutropenia is a frequent complicating feature that heightens susceptibility to severe infections. We describe a patient with a variant of XHIM who produced elevated levels of serum IgA as well as IgM and suffered from chronic severe neutropenia. Eight of ten leukocyte transfusions with cells from a maternal aunt, performed because of mucosal infections, resulted in similar episodes of endogenous granulocyte production. Transfection studies with the mutant CD154 protein indicate that the protein is expressed at the cell surface and forms an aberrant trimer that does not interact with CD40. The data suggest that allogeneic cells from the patient's aunt, probably activated T cells bearing functional CD154, may interact with CD40+ recipient cells to produce maturation of myeloid precursors in the bone marrow.


Subject(s)
Granulocytes/pathology , Hypergammaglobulinemia/genetics , Immunoglobulin M/biosynthesis , Leukocyte Transfusion , X Chromosome , Adolescent , B-Lymphocytes/metabolism , Cell Division/genetics , Cell Division/immunology , Genetic Linkage , Humans , Hypergammaglobulinemia/blood , Hypergammaglobulinemia/immunology , Leukocyte Count , Leukopoiesis , Male , Neutropenia/genetics , Neutropenia/immunology , Syndrome
10.
Rheumatol Int ; 18(1): 21-5, 1998.
Article in English | MEDLINE | ID: mdl-9672995

ABSTRACT

The objective was to assess whether changes of cartilage oligomeric matrix protein (COMP) serum levels can predict the development of osteoarthritis following traumatic knee injury. Sera and synovial fluids were acquired at surgery (T0) and postoperatively during the first (T1) and second (T2) year from 30 knee-injured patients. COMP levels and anti-COMP autoantibodies were quantified by ELISA. Radiographs and patient questionnaires were used to assess outcomes. At T0, compared with controls (1.6 +/- 1.6 micrograms/ml), the serum COMP concentration was significantly elevated (6.5 +/- 2.8 micrograms/ml) with a tendency to further increase (T0 vs. T1, P = 0.076) and subsequently decrease (T1 vs. T2, P = 0.074). However, individual variations are observed, e.g. persistently high (8/30) or increasing (T0 to T2, 8/30) serum COMP. Ten of these patients have elevated COMP at T2 that increased from T0. COMP levels in serum and synovial fluid correlated significantly (P = 0.012). Interestingly, some patients who revealed increasing serum levels of COMP from T0 to T2 displayed anti-COMP autoantibodies. These data suggest that local immune response could contribute to further joint damage. The subgroup of 10 patients (33%) with elevated and increasing serum COMP levels and in particular the patients with antibodies against cartilage matrix molecules appear at increased risk for developing posttraumatic osteoarthritis.


Subject(s)
Cartilage, Articular/injuries , Extracellular Matrix Proteins/blood , Glycoproteins/blood , Knee Injuries/blood , Adult , Autoantibodies/analysis , Biomarkers/blood , Cartilage Oligomeric Matrix Protein , Cartilage, Articular/metabolism , Enzyme-Linked Immunosorbent Assay , Extracellular Matrix Proteins/immunology , Extracellular Matrix Proteins/metabolism , Female , Glycoproteins/immunology , Glycoproteins/metabolism , Humans , Knee Injuries/complications , Knee Injuries/immunology , Male , Matrilin Proteins , Middle Aged , Osteoarthritis/blood , Osteoarthritis/etiology , Prognosis , Surveys and Questionnaires , Synovial Fluid/immunology , Synovial Fluid/metabolism
11.
J Interferon Cytokine Res ; 18(2): 103-15, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9506461

ABSTRACT

The role of antigen-presenting cells (APC) in regulating the balance of T helper type 1 (Th1) and T helper type 2 (Th2) responses and cytokine production is unclear. Dendritic cells (DC), the most potent APC for naive T cell activation, were found to regulate Th1 and Th2 cytokine profiles in a manner dependent on their tissue of origin. Using whole tissues or purified cell mixtures, spleen (systemic) DC were found to induce mainly Th1 cytokines, and Peyer's patch (mucosal) DC were found to induce predominantly Th2 cytokines. Spleen DC induced high levels of interferon-gamma (IFN-gamma) or interleukin-2 (IL-2) or both, and Peyer's patch DC induced IL-4 or IL-6 or both in spleen and Peyer's patch T cells, allogeneic mixed leukocyte reactions, or antigen-specific Th0 clones. These data suggest that the tissue of origin of DC has a significant impact on subsequent T cell development.


Subject(s)
Cytokines/biosynthesis , Dendritic Cells/physiology , Peyer's Patches/pathology , Spleen/pathology , T-Lymphocytes, Helper-Inducer/metabolism , Animals , Cell Division/physiology , Cells, Cultured , Epitopes , Isoantigens/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C3H
12.
J Heart Lung Transplant ; 16(10): 1046-53, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9361247

ABSTRACT

BACKGROUND: Cardiac allograft rejection is largely an inflammatory response that, if allowed to proceed unchecked, will result in hemodynamic compromise or cardiogenic shock. Soluble mediators produced during an inflammatory response could potentially provide information regarding the initiation, progression, and outcome of a rejection episode. To test this hypothesis, we investigated the use of plasma cytokine measurements for interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor alpha (TNF alpha) in combination with measurements of soluble vascular cell adhesion molecule-1 (VCAM-1), an adhesion molecule, as a means for the detection of cardiac allograft rejection. METHODS: Serial enzyme-linked immunosorbent assays were performed on plasma samples collected from 29 patients three times per week during the first 8 weeks after transplantation. RESULTS: IL-6 plasma concentrations increased fivefold in the first week after transplantation (p < 0.001 vs pretransplantation levels) and thereafter remained at low levels for the next 6 weeks, with a small increase during the 8 weeks after transplantation (p = 0.006). In contrast, TNF-alpha, IL-8, and VCAM-1 levels remained low during the first 6 weeks after transplantation followed by a rise in mean VCAM-1 levels from 841 +/- 38 to 979 +/- 52 ng/ml at week 8. To determine the relationship of levels of each of the four soluble factors with rejection, the mean values obtained during the time interval 1 to 5 days before rejection were compared to mean values obtained during rejection and at other periods of no rejection (baseline). Cytokine levels were not predictive of rejection (no difference in levels 0 to 5 days before rejection versus baseline, p > 0.3 for IL-6, IL-8, TNF-alpha). However, VCAM-1 levels increased 0 to 5 days before rejection compared with baseline (914 +/- 40 vs 844 +/- 30 ng/ml, p = 0.06). CONCLUSIONS: IL-6 levels are increased immediately after heart transplantation. Circulating IL-6, IL-8, and TNF alpha levels do not predict rejection during the first 8 weeks after transplantation. Soluble VCAM-1 increases within 5 days before rejection and may potentially serve as a noninvasive marker for early rejection.


Subject(s)
Heart Transplantation , Interleukin-6/blood , Interleukin-8/blood , Tumor Necrosis Factor-alpha/analysis , Vascular Cell Adhesion Molecule-1/blood , Adolescent , Adult , Aged , Biomarkers/blood , Child , Child, Preschool , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Forecasting , Graft Rejection/blood , Graft Rejection/complications , Graft Rejection/immunology , Graft Rejection/physiopathology , Heart Transplantation/immunology , Hemodynamics , Humans , Male , Middle Aged , Sensitivity and Specificity , Shock, Cardiogenic/etiology , Transplantation, Homologous , Treatment Outcome
13.
Plast Reconstr Surg ; 99(5): 1362-7, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9105364

ABSTRACT

Anecdotal, reports have raised the issue of an association between silicone breast implants and the development of rheumatic diseases. Fortunately, this issue has now been extensively addressed by controlled studies, which demonstrate no association between breast implants and rheumatoid arthritis, systemic lupus erythematosus, and scleroderma. Moreover, several studies that now have addressed the issue of "atypical connective tissue disease" indicate no association between a number of rheumatic complaints and silicone breast implants. Additionally, several controlled studies show no evidence of chronic inflammation in patients with silicone breast implants. These observations should be reassuring to women with breast implants and the individuals who care for them.


Subject(s)
Breast Implants/adverse effects , Rheumatic Diseases/etiology , Silicones/adverse effects , Arthritis, Rheumatoid/etiology , Chronic Disease , Connective Tissue Diseases/etiology , Female , Humans , Inflammation , Lupus Erythematosus, Systemic/etiology , Scleroderma, Systemic/etiology
14.
Plast Reconstr Surg ; 99(4): 1054-60, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9091902

ABSTRACT

Breast implants containing silicone have been used for approximately 30 years for breast augmentation or reconstruction. In general, the implants have been well tolerated and reports have indicated a high degree of patient satisfaction. Nonetheless, there have been anecdotal reports of patients with musculoskeletal complaints that have been attributed to silicone breast implants. To investigate this further, we prospectively examined 70 women with silicone breast implants who had complaints that they or their referring physicians thought were related to their implants. On clinical examination, the majority of the patients had fibromyalgia, osteoarthritis, or soft-tissue rheumatism. One patient had rheumatoid arthritis, which predated her implants, and one had Sjõgren's syndrome. Because many of our patients had myalgic symptoms, we further evaluated these patients by measuring circulating levels of soluble factors including interleukin-6, interleukin-8, tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, and soluble interleukin-2 receptor, which have been previously found to be elevated in patients with inflammatory diseases. We found that the levels of these molecules in women with silicone breast implants were not different from those seen in normal subjects and were significantly less than those seen when examining chronic inflammatory disorders such as rheumatoid arthritis or systemic lupus erythematosus. In summary, our clinical and laboratory evaluation of symptomatic breast implant patients argues against an association of silicone breast implants with a distinctive rheumatic disease or a systemic inflammatory disorder. Given these findings and the clinical picture, it is our impression that most symptomatic women with silicone breast implants have well-delineated noninflammatory musculoskeletal syndromes. Moreover, these data fail to support the concept that their symptoms are due to a systemic inflammatory response related to their implants.


Subject(s)
Breast Implants/adverse effects , Rheumatic Diseases/etiology , Silicones/adverse effects , Enzyme-Linked Immunosorbent Assay , Female , Humans , Intercellular Adhesion Molecule-1/blood , Interleukin-6/blood , Interleukin-8/blood , Middle Aged , Prospective Studies , Tumor Necrosis Factor-alpha/analysis
18.
Child Abuse Negl ; 20(12): 1251-9, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8985616

ABSTRACT

Verbal and nonverbal responses by alleged victims of child sexual abuse were coded for length, amount of information, and the manner in which they were elicited by the interviewer. In 16 of the interviews, anatomical dolls were employed for the purposes of demonstration, whereas they were not used in another eight cases matched with respect to other characteristics of the children and the alleged events. Children interviewed with dolls provided an equivalent number of details and spoke as many words in the substantive portion of the interview as did children interviewed without dolls, and interviewers in the two groups used similar probes to elicit information. However, the average responses by the children were significantly longer and more detailed when dolls were not used. Children gave longer and more detailed responses to open-ended invitations when dolls were not used. Caution is necessary when interpreting these findings.


Subject(s)
Child Abuse, Sexual/diagnosis , Interview, Psychological , Play and Playthings , Child , Child Abuse, Sexual/legislation & jurisprudence , Child Abuse, Sexual/psychology , Child, Preschool , Female , Humans , Male , Mental Recall , Truth Disclosure
19.
J Leukoc Biol ; 59(4): 494-8, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8613695

ABSTRACT

The precise role of antigen-presenting cells (APC) in regulating the balance of T-helper type 1 (Th1) and T-helper type 2 (Th2) cytokine production is unclear. Dendritic cells (DC), the most potent APC for activation of naive T cells, were found to regulate Th1 and Th2 cytokine profiles in a fashion dependent upon their tissue of origin. Spleen (systemic) DC induce mainly Th1 cytokines and Peyer's patch (mucosal) DC induce predominantly Th2 cytokines. These findings support the current concept that different tissues, each with its distinct microenvironment of cytokines, hormones, and cellular elements, are involved in the selection, promotion, and/or maintenance of different immune responses. With regard to DC, it is apparent that the tissue of DC origin determines the cytokine profiles produced by T cells and that DC from different tissues favor either cellular versus humoral immune responses by influencing T cell cytokine production.


Subject(s)
Cytokines/biosynthesis , Dendritic Cells/physiology , Th1 Cells/metabolism , Th2 Cells/metabolism , Animals , Humans , Lymphocyte Activation/physiology , Peyer's Patches/cytology , Spleen/cytology
20.
Transplantation ; 61(4): 573-7, 1996 Feb 27.
Article in English | MEDLINE | ID: mdl-8610383

ABSTRACT

The use of OKT3 as an immunosuppressive agent is accompanied by increased cytokine production and constellation of side effects collectively termed cytokine release syndrome (CRS). Pentoxifylline (PTF) inhibits synthesis of some cytokines, and has been shown to attenuate CRS when administered before OKT3. In this double-blinded, placebo-controlled study, 46 renal allograft recipients were randomized to receive either PTF (800 mg q 8 hr for at least 24 h) p.o. or placebo, along with methylprednisolone (7 mg/kg), diphenhydramine, and acetaminophen, prior to beginning OKT3 as therapy for acute rejection. Patients were observed, and symptoms scored semiquantitatively. Despite the presence of therapeutic PTF levels (721 +/- 726 ng/ml), the frequency and severity of side effects (fever, chills, headache, neurocortical symptoms, dyspnea, nausea, vomiting, diarrhea) did not differ between treatment groups. Likewise PTF did not affect renal function or immunologic response to OKT3, with similar graft and patient survival in both groups. Plasma levels of TNF alpha, IFN gamma, IL-6, and IL-8 increased as predicted following OKT3 administration, without significant differences between PTF and placebo groups. In this controlled, multicenter trial, pretreatment with oral PTF was ineffective in attenuating OKT3-related CRS in renal allograft recipients.


Subject(s)
Cytokines/biosynthesis , Immunosuppressive Agents/adverse effects , Muromonab-CD3/adverse effects , Pentoxifylline/therapeutic use , Adult , Animals , CD3 Complex/blood , Cytokines/blood , Double-Blind Method , Female , Humans , Immunosuppressive Agents/therapeutic use , Interferon-gamma/blood , Kidney/immunology , Kidney/physiology , Kidney Transplantation/immunology , Lymphocyte Count/drug effects , Lymphocytes/immunology , Male , Mice , Middle Aged , Muromonab-CD3/therapeutic use , Pentoxifylline/adverse effects , Pentoxifylline/blood , Tumor Necrosis Factor-alpha/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...